“INVESTIGATING THE EFFICACY AND SAFETY OF SGLT2 INHIBITORS FOR CARDIOVASCULAR PROTECTION IN PATIENTS WITH OBESITY AND TYPE 2 DIABETES”. The Research of Medical Science Review, vol. 3, no. 4, Apr. 2025, pp. 307-12, http://www.thermsr.com/index.php/Journal/article/view/929.